Are psychostimulants a treatment option in mania?

Pharmacopsychiatry

Volumn 42, Issue 5, 2009, Pages 169-174

  Hegerl, U ^a   Sander, C ^a   Olbrich, S ^a   Schoenknecht, P ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; METHYLPHENIDATE; MODAFINIL; PSYCHOSTIMULANT AGENT; TRAMADOL; VENLAFAXINE; CENTRAL STIMULANT AGENT;

ALERTNESS; ATTENTION DEFICIT DISORDER; AUTOREGULATION; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; COMORBIDITY; DAYTIME SOMNOLENCE; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; HUMAN; HYPERACTIVITY; MANIA; NARCOLEPSY; PRIORITY JOURNAL; REVIEW; SENSATION; SLEEP APNEA SYNDROME; SLEEP SPINDLE; ANIMAL; ATTENTION; BIOLOGICAL MODEL; BIPOLAR DISORDER; BRAIN; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; MODELS, NEUROLOGICAL;

EID: 70350449475     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0029-1220888     Document Type: Review

References (68)

1. Arns M, Gunkelman J, Breteler M, etal. EEG phenotypes predict treatment outcome to stimulants in children with ADHD. J Integr Neurosci 2008 7 421-438
2. Barbini B, Bertelli S, Colombo C, etal. Sleep loss, a possible factor in augmenting manic episode. Psychiatry Res 1996 65 121-125
3. Barry RJ, Clarke AR, Johnstone SJ. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin Neurophysiol 2003 114 171-183
4. Beckmann H, Heinemann H. D-Amphetamine in manic syndrome. Drug Research 1976 26 1185-1186
5. Benazzi F. Severe mania following abrupt nicotine withdrawal. Am J Psychiatry 1989 146 1641
6. Bente D. Die Insuffizienz des Vigilitätstonus Habilitation: Universität Erlangen 1964
7. Bora E, Vahip S, Akdeniz F. Sustained attention deficits in manic and euthymic patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006 30 1097-1102
8. Bora E, Vahip S, Akdeniz F, etal. The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients. Bipolar Disord 2007 9 468-477
9. Brown WA, Mueller B. Alleviation of manic symptoms with catecholamine agonists. Am J Psychiatry 1979 136 230-231
10. Bschor T, Muller-Oerlinghausen B, Ulrich G. Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study. Clin Electroencephalogr 2001 32 36-39
11. Carlson PJ, Merlock MC, Suppes T. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. Bipolar Disord 2004 6 416-420
12. Chervin RD, Archbold KH, Dillon JE, etal. Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep 2002 25 213-218
13. Chesson AL, Wise M, Davila D, etal. Practice parameters for the treatment of Restless Legs Syndrome and periodic limb movement disorder. Sleep 1999 22 961-968
14. Clark L, Goodwin GM. State- and trait-related deficits in sustained attention in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2004 254 61-68
15. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002 180 313-319
16. Dahl RE, Pelham WE, Wierson M. The role of sleep disturbances in attention-deficit disorder symptoms: A case study. J Pediatr Psychol 1991 16 229-239
17. De Gennaro L, Ferrara M, Curcio G, etal. Antero-posterior EEG changes during the wakefulness-sleep transition. Clin Neurophysiol 2001 112 1901-1911
18. Eysenck HJ. Biological dimensions of personality. In: Pervin LA, editor. Handbook of personality: Theory and research New York: Guilford Press 1990 244-276
19. Fallone G, Acebo C, Arnedt JT, etal. Effects of acute sleep restriction on behavior, sustained attention, and response inhibition in children. Percept Motor Skills 2001 93 213-229
20. Fernandes PP, Petty F. Modafinil for remitted bipolar depression with hypersomnia. Ann Pharmacother 2003 37 1807-1809
21. Frye MA, Grunze H, Suppes T, etal. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 2007 164 1242-1249
22. Galanter CA, Carlson GA, Jensen PS, etal. Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol 2003 13 123-136
23. Garvey MJ, Hwang S, Teubner-Rhodes D, etal. Dextroamphetamine treatment of mania. J Clin Psychiatry 1987 48 412-413
24. Gelperin K, Phelan K. Psychiatric adverse events associated with drug treatment of ADHD: review of postmarketing safety data. FD Report PID D050243. US Food and Drug Administration, March 3 2006 Availabe at: www.fda.gov/ohrms/ dockets/ac/06/briefing/2006-4210b-11-01-adverseevents.pdf
25. Golan N, Shahar E, Ravid S, etal. Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactive disorder. Sleep 2004 27 261-266
26. Goodwin FK, Jamison KR. Manic-depressive illness, 2nd edition Oxford University Press 2007
27. Hegerl U, Stein M, Mulert C, etal. EEG-vigilance differences between patients with borderline personality disorder, patients with obsessive-compulsive disorder and healthy controls. Eur Arch Psychiatry Clin Neurosci 2008 258 137-143
28. Janowsky DS, Elyousef MK, Davis JM, etal. Provocation of schizophrenic symptoms by intravenous administration of Methylphenidate. Arch Gen Psychiatry 1973 28 185-191
29. Jones RM, Thompson C, Bitter I. A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania. Eur Psychiatry 2006 21 1-9
30. Kessing LV, Agerbo E, Mortensen PB. Major stressful life events and other risk factors for first admission with mania. Bipolar Disord 2004 6 122-129
31. Labbate LA. Nicotine cessation, mania, and depression. Am J Psychiatry 1992 149 708
32. Lambert M, Huber CG, Naber D, etal. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder. Pharmacopsychiatry 2008 41 182-189
33. LeBourgeois MK, Avis K, Mixon M, etal. Snoring, sleep quality, and sleepiness across attention-deficit/hyperactivity disorder subtypes. Sleep 2004 27 520-525
34. Leibenluft E, Suppes T. Treating bipolar illness: Focus on treatment algorithms and management of the sleep-wake cycle. Am J Psychiatry 1999 156 1976-1981
35. Lewin DS, DiPinto M. Sleep disorders and ADHD: Shared and common phenotypes. Sleep 2004 27 188-189
36. Malkoff-Schwartz S, Frank E, Anderson BP, etal. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol Med 2000 30 1005-1016
37. Menza MA, Kaufman KR, Castellanos A. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 2000 61 378-381
38. Mosholder A. Psychiatric adverse events in clinical trials of drugs for ADHD. FDA Report PID D060163. US Food and Drug Administration, March 3 2006 Available at: www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4210b-10-01- mosholder.pdf
39. Nierenberg AA, Miyahara S, Spencer T, etal. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: Data from the first 1000 STEP-BD participants. Biol Psychiatry 2005 57 1467-1473
40. Oken BS, Salinsky MC, Elsas SM. Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol 2006 117 1885-1901
41. Olbrich S, Mulert C, Karch S, etal. EEG-vigilance and BOLD-effect. Neuroimage 2009 45 319-342
42. Pliszka SR. Pharmacologic treatment of attention-deficit/hyperactivity disorder: Efficacy, safety and mechanisms of action. Neuropsychol Review 2007 17 61-72
43. Puls I, Gallinat J. The concept of endophenotypes in psychiatric diseases meeting the expectations? Pharmacopsychiatry 2008 41 (Suppl 1) 37-43
44. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord 2002 72 209-226
45. Ranjan S, Chandra PS. Modafinil-induced irritability and aggression* A report of 2 bipolar patients. J Clin Psychopharmacol 2005 25 628-629
46. Reckow S, Gormanns P, Holsboer F, etal. Psychiatric disorders biomarker identification: from proteomics to systems biology. Pharmacopsychiatry 2008 41 (Suppl 1) 70-77
47. Ross RG. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2006 163 1149-1152
48. Roth B. The clinical and theoretical importance of EEG rhythms corresponding to states of lowered vigilance. Electroencephalogr Clin Neurophysiol 1961 13 395-399
49. Santamaria J, Chiappa KH. The EEG of drowsiness in normal adults. J Clin Neurophysiol 1987 4 327-382
50. Savitz J, Solms M, Ramesar R. Neuropsychological dysfunction in bipolar affective disorder: A critical opinion. Bipolar Disord 2005 7 216-235
51. Scheffer RE, Kowatch RA, Carmody T, etal. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 2005 162 58-64
52. Schildkraut JJ. The catecholamine hypothesis of affective disorders A review of supporting evidence. Am J Psychiatry 1965 122 509-522
53. Singh MK, DelBello MP, Kowatch RA, etal. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children. Bipolar Disord 2006 8 710-720
54. Small JG, Milstein V, Malloy FW, etal. Clinical and quantitative EEG studies of mania. J Affect Disord 1999 53 217-224
55. Strijkstra AM, Beersma DGM, Drayer B, etal. Subjective sleepiness correlates negatively with global alpha (812Hz) and positively with central frontal theta (48Hz) frequencies in the human resting awake electroencephalogram. Neurosci Lett 2003 340 17-20
56. Tanaka H, Hayashi M, Hori T. Statistical features of hypnagogic EEG measured by a new scoring system. Sleep 1996 19 731-738
57. Tsuno N, Shigeta M, Hyoki K, etal. Spatial organization of EEG activity from alertness to sleep stage 2 in old and younger subjects. J Sleep Res 2002 11 43-51
58. Ulrich G. Psychiatrische Elektroenzephalographie Jena: Gustav Fischer Verlag 1994
59. Van Sweden B. Disturbed vigilance in mania. Biol Psychiatry 1986 21 311-313
60. Vorspan F, Warot D, Consoli A, etal. Mania in a boy treated with modafinil for narcolepsy. Am J Psychiatry 2005 162 813-814
61. Wagner ML, Walters AS, Fisher BC. Symptoms of attention-deficit/ hyperactivity disorder in adults with restless legs syndrome. Sleep 2004 27 1499-1504
62. Walters AS, Mandelbaum DE, Lewin DS, etal. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Pediatr Neurol 2000 22 182-186
63. Wehr TA. Improvement of depression and triggering of mania by sleep-deprivation. JAMA 1992 267 548-551
64. Wilder-Willis KE, Sax KW, Rosenberg HL, etal. Persistent attentional dysfunction in remitted bipolar disorder. Bipolar Disord 2001 3 58-62
65. Wingo AP, Ghoemi SN. Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients. Psychopharmacol Bull 2008 41 37-47
66. Wolf J, Fiedler U, Anghelescu I, etal. Manic switch in a patient with treatment-resistant bipolar depression treated with modafinil. J Clin Psychiatry 2006 67 1817
67. Wundt W. Grundzüge der physiologischen Psychologie, 4. Auflage Engelmann, Leipzig 1893
68. Zuckerman M. Sensation seeking, mania, and monoamines. Neuropsychobiology 1985 13 121-128